Quince Therapeutics QNCX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 1.01 | 2.88 | -11,112 | 36 | ||
| 2025Q4 | 33.5 | 53.3 | -7.6 | -19,353 | -39 | |
| 2025Q3 | 16.3 | 99.57 | -2.3 | -13,430 | -13 | |
| 2025Q2 | 16.5 | 65.24 | -3.5 | -10,427 | -16 | |
| 2025Q1 | 13.3 | 99.17 | -3.4 | -14,858 | -15 | |
| 2024Q4 | 18.7 | 96.47 | -2.8 | -12,012 | -12 | |
| 2024Q3 | 7.76 | 107.01 | -1.3 | -5,863 | -5 | |
| 2024Q2 | 7.5 | 101.8 | -6.4 | -28,192 | -28 | |
| 2024Q1 | 10.6 | 100.9 | -2.6 | -11,218 | -11 | |
| 2023Q4 | 10.5 | 112.19 | -2.1 | -9,921 | -9 | |
| 2023Q3 | 11.2 | 115.1 | -1.5 | -6,159 | -5 | |
| 2023Q2 | 15.05 | 114.29 | -1.4 | -5,584 | -5 | |
| 2023Q1 | 15.6 | 103.63 | -3.4 | -12,956 | -12 | |
| 2022Q4 | 6.37 | 114.19 | -1.3 | -6,319 | -6 | |
| 2022Q3 | 13.3 | 96.2 | -1.9 | -7,620 | -8 | |
| 2022Q2 | 22.2 | 96.23 | -5 | -16,213 | -17 | |
| 2022Q1 | 61.9 | 101.03 | -7.2 | -21,863 | -22 | |
| 2021Q4 | 126.2 | -7.8 | -23,544 | -23 | ||
| 2021Q3 | 916.6 | -7.3 | -21,677 | -22 | ||
| 2021Q2 | 530 | -7.4 | -21,783 | -22 |